Physician profile
Presley E Pearman
NPI 1740737337
$8,002.55
in general payments reported to CMS, 2019-2025
23 companies · $18.79 in 2025
The $18.79 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,666 · 2022: $2,513 · 2023: $2,750 · 2024: $1,054 · 2025: $18.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,630 · Education: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,629.67 |
| Education | $193.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,167.59 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $998.03 | 2021-2025 | |
| Leo Pharma INC. | $582.20 | 2022-2024 | Adbry |
| Amgen INC. | $568.87 | 2021-2024 | Otezla |
| Pfizer INC. | $535.03 | 2021-2024 | |
| Janssen Biotech, INC. | $496.62 | 2021-2024 | Tremfya |
| Sun Pharmaceutical Industries INC. | $450.87 | 2021-2024 | Ilumya |
| Lilly USA, LLC | $440.66 | 2021-2024 | Olumiant, Taltz |
| Incyte Corporation | $383.47 | 2021-2024 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $317.00 | 2022-2023 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $309.53 | 2023-2024 | Siliq, Duobrii, Targretin |
| Almirall LLC | $300.00 | 2021 | |
| Arcutis Biotherapeutics, INC. | $292.38 | 2023-2024 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $286.48 | 2021-2024 | Dupixent |
| Dermavant Sciences, INC. | $272.74 | 2023-2024 | Vtama |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $136.37 | 2021-2023 | Cimzia |
| Stemline Therapeutics INC. | $129.40 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.52 | 2023-2024 | Spevigo, Cyltezo |
| Galderma Laboratories, L.P. | $80.35 | 2021 | |
| Genzyme Corporation | $69.13 | 2021-2023 | |
| Epi Health, LLC | $28.57 | 2022 | |
| Mayne Pharma Commercial LLC | $26.42 | 2023 | |
| Journey Medical Corporation | $24.32 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Presley Pearman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.